Global Famciclovir API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Famciclovir API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)

According to our (Global Info Research) latest study, the global Famciclovir API market size was valued at US$ 13.7 million in 2023 and is forecast to a readjusted size of USD 16 million by 2030 with a CAGR of 2.2% during review period.

The classification of Famciclovir API includes Insourced and Outsourced. In addition, the proportion of Insulin Outsourced in 2019 is about 71%, and the proportion is in increasing trend from 2015 to 2020.

Famciclovir API is widely used in Tablet Product, Capsule Product and Others Product. The most proportion of Famciclovir API is used in Tablet Product, and the proportion in 2019 is about 80%.

Asia-Pacific is the largest consumption market, with a market share nearly 48% in 2019. Following Asia-Pacific, North America is the second largest consumption market with the market share of about 21%.

Market competition is intense. Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

This report is a detailed and comprehensive analysis for global Famciclovir API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Famciclovir API market size and forecasts, in consumption value ($ Million), sales quantity (KG), and average selling prices (US$/KG), 2019-2030

Global Famciclovir API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (KG), and average selling prices (US$/KG), 2019-2030

Global Famciclovir API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (KG), and average selling prices (US$/KG), 2019-2030

Global Famciclovir API market shares of main players, shipments in revenue ($ Million), sales quantity (KG), and ASP (US$/KG), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Famciclovir API

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Famciclovir API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, Olon, Fuan Pharmaceutical, Zhejiang Charioteer Pharmaceutical, Jialin Pharmaceutical, Zhejiang Hisun, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Famciclovir API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Insourced
Outsourced
Others

Market segment by Application
Tablet Product
Capsule Product
Others

Major players covered
Chongqing Shenghuaxi Pharma
Aurobindo Pharma Limited
Apotex Pharmachem
Changzhou Kony Pharma Co
Teva Pharmaceutical Industries
Olon
Fuan Pharmaceutical
Zhejiang Charioteer Pharmaceutical
Jialin Pharmaceutical
Zhejiang Hisun
Hetero

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Famciclovir API product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Famciclovir API, with price, sales quantity, revenue, and global market share of Famciclovir API from 2019 to 2024.

Chapter 3, the Famciclovir API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Famciclovir API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Famciclovir API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Famciclovir API.

Chapter 14 and 15, to describe Famciclovir API sales channel, distributors, customers, research findings and conclusion.